By Mass Tort Attorneys Keith E. Donovan and Matthew R. Fogg On June 4, 2026, a federal panel combined all of the Dupixent lawsuits into...

By Morris James Mass Torts Attorneys Matthew R. Fogg and Keith E. Donovan If you or a loved one was diagnosed with cutaneous T-cell...

Dupixent (dupilumab) has been a genuine breakthrough for many families. For children with moderate-to-severe eczema, asthma, and other...

By: Keith Donovan and Matthew Fogg The FDA has expanded approval of Dupixent® (dupilumab) for children aged six and older with allergic...

For many people living with severe eczema, Dupixent feels like a breakthrough. After years of painful flare-ups, constant itching, and...

If you or someone you love uses Dupixent, you may have recently seen television ads or online headlines linking the medication to rare...

When we take prescription medications, we trust that they will help us feel better, not leave us with devastating side effects we were...

Morris James' Managing Partner, Keith Donovan, has been named a Delaware 222 Honoree by Delaware Business Times for his contributions to...

A diagnosis of T-cell lymphoma after using Dupixent raises serious questions for patients and families. Many want clear answers about...

By: Keith Donovan and Matt Fogg When you start a medication like Dupixent (dupilumab), you expect relief from eczema or asthma, not the...

The first known lawsuit has now been filed against the makers of Dupixent (dupilumab), alleging that the popular eczema and asthma drug...

As more patients come forward with questions about the potential link between dupilumab (Dupixent®) and certain types of cancer, it’s...

Morris James LLP is investigating claims on behalf of patients who developed cutaneous T-cell lymphoma (CTCL) after being prescribed...